Lactylation of tau in human Alzheimer's disease brains
Alzheimer's & Dementia · 2025-02 · 21 (2)
DOI: 10.1002/alz.14481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 30.12.2024. Verfasst von Xiaoyu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Brain, Protein Processing, Post-Translational. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Aggregation of hyperphosphorylated tau (tauopathy) is associated with cognitive impairment in patients with Alzheimer's disease (AD). In AD, a metabolic shift due to the Warburg effect results in increased lactate production. Lactate can induce a post‐translational modification (PTM) on proteins that conjugates lactyl groups to lysine (K) residues, which is known as lactylation. METHODS We analyzed lactylation of tau in control and AD brain tissue and conducted cell‐based assays. In addition, we used in vitro assays to determine whether p300 catalyzed tau lactylation. RESULTS Quantitative proteomics detected that tau lactylation was elevated in AD brains, with K residue at position 331 (K331) being a prominent site. Lactate induced tau lactylation, which increased tau phosphorylation and cleavage and reduced ubiquitination. Inhibition of lactate production lowered tau lactylation; p300 catalyzed tau lactylation. DISCUSSION Our findings suggest that tau lactylation links metabolic dysregulation with tauopathy and could serve as a novel diagnostic and therapeutic target. Highlights Elevated tau lactylation, particularly at K331, is evident in in human AD brain samples. Lactate induces tau lactylation, enhancing phosphorylation and cleavage while inhibiting ubiquitination. The acetyl‐transferase p300 catalyzes tau lactylation, with K331 being the most prominent site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Institute of Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Mass Spectrometry/Proteomics Core Laboratory, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Landon Center on Aging, University of Kansas Medical Center, Kansas City, Kansas, USA.
- University of Kansas Alzheimer's Disease Research Center, Fairway, Kansas, USA.
ORCID-Profile: Ning Wang
Förderung
- NICHD NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- University of Kansas Alzheimer's Disease Research Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Landon Center on Aging
- Kansas IDeA Network of Biomedical Research Excellence
Zitieren
APA
Zhang, X., Liu, Y., Rekowski, M. J., & Wang, N. (2025). Lactylation of tau in human Alzheimer's disease brains. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14481
Vancouver
Zhang X, Liu Y, Rekowski MJ, Wang N. Lactylation of tau in human Alzheimer's disease brains. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14481
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoyu and Liu, Yan and Rekowski, Michaella J and Wang, Ning},
title = {Lactylation of tau in human Alzheimer's disease brains},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {2},
doi = {10.1002/alz.14481}
}
EUVIMED